Kronox Lab Sciences IPO is a book built issue of Rs 130.15 crores. The issue is entirely an offer for sale of 0.96 crore shares.
Kronox Lab Sciences IPO opens for subscription on June 3, 2024 and closes on June 5, 2024. The allotment for the Kronox Lab Sciences IPO is expected to be finalized on Thursday, June 6, 2024. Kronox Lab Sciences IPO will list on BSE, NSE with tentative listing date fixed as Monday, June 10, 2024.
Kronox Lab Sciences IPO price band is set at ₹129 to ₹136 per share. The minimum lot size for an application is 110 Shares. The minimum amount of investment required by retail investors is ₹14,960. The minimum lot size investment for sNII is 14 lots (1,540 shares), amounting to ₹209,440, and for bNII, it is 67 lots (7,370 shares), amounting to ₹1,002,320.
Pantomath Capital Advisors Pvt Ltd is the book running lead manager of the Kronox Lab Sciences IPO, while Kfin Technologies Limited is the registrar for the issue.
Refer to Kronox Lab Sciences IPO RHP for detailed information.
Kronox Lab Sciences IPO Details
| IPO Date | June 3, 2024 to June 5, 2024 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Price Band | ₹129 to ₹136 per share |
| Lot Size | 110 Shares |
| Total Issue Size | 9,570,000 shares (aggregating up to ₹130.15 Cr) |
| Offer for Sale | 9,570,000 shares of ₹10 (aggregating up to ₹130.15 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 37,104,000 |
| Share holding post issue | 37,104,000 |
Kronox Lab Sciences IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
Kronox Lab Sciences IPO Timeline (Tentative Schedule)
Kronox Lab Sciences IPO opens on June 3, 2024, and closes on June 5, 2024.
| IPO Open Date | Monday, June 3, 2024 |
| IPO Close Date | Wednesday, June 5, 2024 |
| Basis of Allotment | Thursday, June 6, 2024 |
| Initiation of Refunds | Friday, June 7, 2024 |
| Credit of Shares to Demat | Friday, June 7, 2024 |
| Listing Date | Monday, June 10, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on June 5, 2024 |
Kronox Lab Sciences IPO Lot Size
Investors can bid for a minimum of 110 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 110 | ₹14,960 |
| Retail (Max) | 13 | 1430 | ₹194,480 |
| S-HNI (Min) | 14 | 1,540 | ₹209,440 |
| S-HNI (Max) | 66 | 7,260 | ₹987,360 |
| B-HNI (Min) | 67 | 7,370 | ₹1,002,320 |
| Lot Size Calculator | |||
Kronox Lab Sciences IPO Promoter Holding
The Promoters of the Company are Jogindersingh Jaswal, Ketan Ramani and Pritesh Ramani.
| Share Holding Pre Issue | 99.98% |
| Share Holding Post Issue |
About Kronox Lab Sciences Limited
Incorporated in 2008, Kronox Lab Sciences Limited is a manufacturer of high-purity speciality fine chemicals for diverse end-user industries. The company’s High Purity Specialty Fine Chemicals are used in various applications such as manufacturing APIs, pharmaceutical formulations, scientific research, nutraceuticals, biotech applications, agrochemical formulations, personal care products, metal refineries, and animal health products.
The company offers a wide range of over 185 products, including phosphate, sulphate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, succinate, gluconate, and others. These products are supplied to customers in India and more than 20 countries worldwide.
The company exports its products to countries such as United States, Argentina, Mexico, Australia, Egypt, Spain, Turkey, United Kingdom, Belgium, United Arab Emirates, China, among others.
The company has three manufacturing facilities in Vadodara, Gujarat, close to the seaports of Mundra, Kandla, Hazira, and Nhava Sheva. The facilities cover 17,454 sq. m. and have an installed capacity of 7,242 TPA as of December 31, 2023. Unit I/II holds FSSC 22000 (Version 5), ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 certifications. Additionally, some products manufactured at Unit I have obtained Kosher, Halal, GMP, and GLP certifications.
As of December 31, 2023, the company is conducting research and development on 122 products.
The company has served over 592 customers in the past three years. By December 31, 2023, 141 customers of the total, placed repeat orders.
As of December 31, 2023, the company employees 212 people at various levels.
Kronox Lab Sciences Limited Financial Information (Restated)
Kronox Lab Sciences Limited’s revenue increased by 16.99% and profit after tax (PAT) rose by 21.94% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
| Assets | 66.96 | 54.03 | 56.79 | 37.65 |
| Revenue | 68.44 | 97.50 | 83.34 | 63.24 |
| Profit After Tax | 15.47 | 16.62 | 13.63 | 9.73 |
| Net Worth | 60.28 | 44.68 | 40.35 | 26.81 |
| Reserves and Surplus | 15.56 | 7.58 | 40.11 | 26.57 |
| Total Borrowing | 0.64 | 0.01 | ||
| Amount in ₹ Crore | ||||
Key Performance Indicator
The market capitalization of Kronox Lab Sciences IPO is Rs 504.61 Cr.
KPI as of December 31, 2023.
| KPI | Values |
|---|---|
| ROE | 25.66% |
| ROCE | 33.15% |
| RoNW | 25.66% |
| P/BV | 8.37 |
| PAT Margin (%) | 22.6 |
Check Kronox Lab Sciences IPO Peer Comparison here.
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 4.48 | 5.56 |
| P/E (x) | 30.37 | 24.47 |
Note:
- The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2023 that is available in RHP.
- The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of December 31, 2023 that is available in RHP.
Objects of the Issue (Kronox Lab Sciences IPO Objectives)
The Objects of the Offer are to:
- Carry out the Offer for Sale of up to 95,70,000 Equity Shares by the Promoter Selling Shareholders; and
- Achieve the benefits of listing the Equity Shares on the Stock Exchanges. Further, the Company expects that the proposed listing of the Equity Shares will enhance the visibility and brand image, provide liquidity to its existing Shareholders, and provide a public market for Equity Shares in India.
Kronox Lab Sciences IPO Prospectus
Kronox Lab Sciences Limited Contact Details
Kronox Lab Sciences Limited
Block No. 353,
Village Ekalbara, Padra,
Vadodara-391440
Phone: +91 26 6224 4077/88
Email: cs@kronoxlabsciences.com
Website: https://www.kronoxlabsciences.com/
Kronox Lab Sciences IPO Registrar
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: klsl.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/